CG Oncology Inc.

Last updated September 27, 2026

Organization details

Legal name
CG Oncology Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Dallas
Headquarters state / province
Texas
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CGON
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001991792
EIN
37-1611499

Board of directors

Chief executives

Arthur Kuan · Chief Executive Officer
Since January 2024
100 CEO score

Outstanding · grade A+

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
100

345% a year in revenue

20% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 3 other boards. 3 are in the same sector.

Network of CG Oncology Inc.'s board connections Aardvark Therapeutics Inc. Aardvark Therapeutics... Xilio Therapeutics Inc. Xilio Therapeutics Inc... uniQure N.V. uniQure N.V. Christina Rossi Christina Rossi Leonard E. Post Leonard E. Post Susan E. Graf Susan E. Graf Victor Edward Tong Jr. Victor Edward Tong J... CG Oncology Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$24,814,454
1 purchase by 1 insider
Sold, last 12 months
$4,834,471
17 sales by 2 insiders
Date Insider Transaction Shares Price Value
Oct 15, 2026 Leonard E. Post Director Option exercise +1,000 $0.60 $600
Oct 15, 2026 Leonard E. Post Director Open-market sale −500 $61.65 $30,825
Oct 15, 2026 Leonard E. Post Director Open-market sale −500 $62.48 $31,240
Sep 15, 2026 Leonard E. Post Director Option exercise +1,000 $0.60 $600
Sep 15, 2026 Leonard E. Post Director Open-market sale −1,000 $72.98 $72,980
Aug 14, 2026 Leonard E. Post Director Option exercise +1,000 $0.60 $600
Aug 14, 2026 Leonard E. Post Director Open-market sale −1,000 $74.54 $74,540
Jul 15, 2026 Leonard E. Post Director Option exercise +1,000 $0.60 $600
Jul 15, 2026 Leonard E. Post Director Open-market sale −1,000 $71.17 $71,170
Jul 10, 2026 James Mulay Director Option exercise +24,165 $26.63 $643,514
Jul 10, 2026 James Mulay Director Open-market sale −24,165 $75.16 $1,816,241
Jun 25, 2026 Brian Guan-Chyun Liu Director Open-market purchase +371,085 $66.87 $24,814,454
Jun 24, 2026 Leonard E. Post Director Option exercise +5,000 $0.60 $3,000
Jun 24, 2026 Leonard E. Post Director Open-market sale −5,000 $70.00 $350,000
Jun 22, 2026 Leonard E. Post Director Option exercise +5,000 $0.60 $3,000

Organizations in the same sector, closest in location and size first.

Questions about CG Oncology Inc.

Who is the CEO of CG Oncology Inc.?

Arthur Kuan has been CG Oncology Inc.'s Chief Executive Officer since January 2024.

How many directors are on CG Oncology Inc.'s board?

CG Oncology Inc.'s board has 8 directors: Arthur Kuan, Brian Guan-Chyun Liu, Christina Rossi, Hong Fang Song, James Mulay, Leonard E. Post, Susan E. Graf and Victor Edward Tong Jr.

Are CG Oncology Inc. insiders buying or selling shares?

Over the last 12 months, CG Oncology Inc. insiders bought $24.8 million of shares in 1 purchase and sold $4.8 million of shares in 17 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="cg-oncology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.